Showing posts with label Hospital Acquired Disease Testing Market analysis. Show all posts
Showing posts with label Hospital Acquired Disease Testing Market analysis. Show all posts
Hospital Acquired Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
This
report covers the market analysis for various diagnostic tests
performed to detect hospital associated infections, also called as
nosocomial infections. These infections are not present in an
individual before being admitted to hospital; instead the infections
are developed after the admittance. Pathogens, primarily viral,
bacterial and fungal are the main cause for the prevalence of
nosocomial infections as they spread easily through the individual’s
body and thereby deteriorate the immune system. The infections are
mainly acquired from other patients, hospital staff, and contaminated
objects, acting as potential vectors. Morbidity rate of nosocomial
infections is increasing rapidly worldwide, hence driving the
hospital associated infection (HAI) diagnostic market towards
remarkable growth. The stakeholders for this study include
manufacturers and providers of diagnostic solutions for nosocomial
infections. Therefore, the global hospital acquired disease testing
market possesses tremendous growth potential, especially in the
developing nations.
Browse Here For Full Report With
ToC:http://www.transparencymarketresearch.com/hospital-acquired-disease-testing.html
This
research report provides a detailed analysis of the global hospital
acquired disease testing market and also aids in understanding the
various driving factors for the growth of this market. The executive
summary comprises the market snapshot which provides information
about segments and sub-segments. The market overview section of the
report demonstrates market dynamics and market trends such as the
drivers, restraints and opportunities that influence the current
nature and future status of this market. Impact factors such as
market attractiveness analysis and Porter’s five forces analysis of
key market players have also been explained in the market overview
section of the report, in order to give a thorough analysis of the
overall competitive scenario in the hospital acquired disease testing
market. All these factors would help the market players to gain
thorough analysis of the overall competitive scenario and thereby
decide upon the business strategies and plans to be incurred in
future for the global hospital acquired disease testing market.
“We are currently offering a flat 15% discount on all purchases
until end of the March 2015!”
The
global hospital acquired disease testing market is categorized on the
basis of infection types and geography. The market estimates from
2011 to 2019 for each of these segments is provided in USD million.
The global hospital acquired disease testing market, based on the
type of infection is segmented into urinary tract infection (UTI)
testing, surgical site infection(SSI) testing, pneumonia testing,
blood stream infection (BSI) testing, methicillin-resistant
staphylococcus aureus (MRSA) testing, and others (GI, bone,
respiratory, cardiovascular, etc.). A detailed market analysis and
forecast for these segments has been provided in this study in terms
of market revenue (USD million) for the period 2011 to 2019. The
report also provides the compounded annual growth rate (CAGR %) for
each infection type for the forecast period 2013 to 2019, while
market size estimations have been made considering 2012 as the base
year.
Based
on geography, the global hospital acquired disease testing market has
been segmented into four major regions: North America, Europe, Asia
Pacific and Rest of the World. The current and future market sizes
(in terms of USD million) of the above regional markets have been
provided in the report for the period 2011 to 2019 with their growth
rate (%) for the period 2013 to 2019. The study further offers
recommendations and highlights of the market, which would be useful
for the existing and new market players to sustain and grow in the
global hospital acquired disease testing market.
Click Here For Press Release
: http://www.transparencymarketresearch.com/pressrelease/hospital-acquired-disease-testing.htm
This
report concludes with the company profiles section which includes key
information such as company overview, financial overview, product
portfolio, business strategies and recent developments about the
major market players in hospital acquired disease testing market.
Some of the key players profiled in this report include Diatherix
Laboratories, Inc., Gen-Probe, Inc., Qiagen GmbH, L Hoffman La
Roche,Cepheid, Inc., Life Technologies Corporation, Meridian
Biosciences, Cantel Medical Corporation, Nordion, Inc.and others.
Subscribe to:
Posts
(
Atom
)
